Nat West Group PLC Abbott Laboratories Transaction History

Nat West Group PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 27, 2023	SELL	$95.06 - $111.52 $60,172 - $70,592	-633 Reduced 2.62%	23,499 $0
Q3 2022 Oct 31, 2022	SELL	$96.76 - $112.03 $983,662 - $1.14 Million	-10,166 Reduced 29.64%	24,132 $2.34 Million
Q2 2022 Jul 20, 2022	BUY	$102.07 - $123.37 $179,234 - $216,637	1,756 Added 5.4%	34,298 $3.73 Million
Q1 2022 May 03, 2022	BUY	$114.02 - $139.04 $3.71 Million - $4.52 Million	32,542 New	32,542 $3.85 Million
Q4 2017 Feb 06, 2018	SELL	$53.68 - $57.47 $700,201 - $749,638	-13,044 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $626,894 - $699,680	13,044	13,044 $696,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Nat West Group PLC, based on Form 13F filings with the SEC.

Stay updated on Nat West Group PLC with notifications on news.